H.C. Wainwright Keeps Their Buy Rating on Lexicon Pharmaceuticals (LXRX)
In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), ...